Winton Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,340
Closed -$1.54M 624
2024
Q1
$1.54M Buy
+22,340
New +$1.41M 0.11% 159
2021
Q2
Sell
-3,354
Closed -$442K 1445
2021
Q1
$442K Sell
3,354
-612
-15% -$83.8K 0.03% 951
2020
Q4
$525K Buy
+3,966
New +$480K 0.04% 767
2020
Q3
Sell
-4,902
Closed -$426K 1517
2020
Q2
$426K Sell
4,902
-19,072
-80% -$1.52M 0.01% 1218
2020
Q1
$1.39M Buy
23,974
+21,436
+845% +$1.74M 0.04% 676
2019
Q4
$235K Sell
2,538
-714
-22% -$62.8K ﹤0.01% 1419
2019
Q3
$294K Sell
3,252
-1,792
-36% -$204K ﹤0.01% 1279
2019
Q2
$595K Sell
5,044
-1,787
-26% -$180K 0.01% 600
2019
Q1
$592K Sell
6,831
-4,787
-41% -$407K 0.01% 510
2018
Q4
$733K Buy
11,618
+5,338
+85% +$366K 0.02% 392
2018
Q3
$496K Sell
6,280
-969
-13% -$63.2K 0.01% 630
2018
Q2
$433K Sell
7,249
-9,286
-56% -$500K 0.01% 679
2018
Q1
$667K Buy
+16,535
New +$807K 0.02% 655

Other funds holding EXAS

Winton Group's EXAS Position: Q2 2024 in Review

Winton Group sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 22,340 shares — an estimated $1.54M sold.

Winton Group first reported a position in EXAS in Q1 2018 and held it in 13 quarters. The position peaked at $1.54M in Q1 2024. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Winton Group reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Winton Group sold 22,340 Exact Sciences shares in Q2 2024, an estimated $1.54M.
  • Winton Group first reported a position in Exact Sciences in Q1 2018 and held it in 13 quarters.
  • Winton Group's Exact Sciences position peaked at $1.54M in Q1 2024.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Winton Group's 13F filing for Q2 2024, filed 9 Aug 2024.